The great majority (50–60%) of nucleotide substitutions in LDLR are missense mutations, further increasing the difficulty of DNA-based diagnosis of heterozygous forms of FH, since for each genetic alteration discovered the causal role in the development of hypercholesterolemia must be demonstrated (Mandelshtam, 2011). The gene discussed is LDLR; the disease is familial hyperaldosteronism.